AI assistant
Sending…
SynAct Pharma — Major Shareholding Notification 2023
Feb 1, 2023
3114_iss_2023-02-01_d943e3b7-d509-49a0-b0cf-e8ca26afccfc.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
{# SEO P0-1: filing HTML is rendered server-side so Googlebot
sees the full text without executing JS or following an
iframe to a Disallow'd CDN path. The content has already
been sanitized through filings.seo.sanitize_filing_html. #}

Issuer SynAct Pharma AB
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktie SE0008241491 |
|---|---|
| Before the transaction | |
| Shares | 1,487,261 |
| Voting rights | 1,487,261 |
| Transaction | |
| Reason for major shareholding notification Corporate action | |
| Date | 31/01/2023 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,486,807 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,486,807 |
| Percentage | |
| Directly held shares | 4.67241 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.67241 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.67241 % | 1,486,807 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.67241 % | 1,486,807 |
| Chain of controlling companies |
Percentage of voting rights 4.67241
| Voting rights % Voting rights Company | |||
|---|---|---|---|
| 1,460,983 4.59126 | Nordnet Pensionsförsäkring AB | ||
| 25,824 | 0.08115 | Nordnet Livsforsikring AS | |
| Group total holdings |
|||
| Voting rights | 1,486,807 |
Notes (other relevant informations according to law)
Nordnet AB (publ) genom Nordnet Pensionsförsäkring AB och Nordnet Livsforsikring AS har underskridit tröskelvärdet 5% av antalet utestående aktier och röster till följd av nytt antal utestående aktier och röster.
Published
01/02/2023 11:36
Contact
Name David Ohlsson Phone +46709497952 Email [email protected]

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from SynAct Pharma
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Board/Management Information
2026
Apr 23
Governance Information
2026
Apr 23
Annual Report (ESEF)
2026
Apr 15
Major Shareholding Notification
2026
Apr 7
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Major Shareholding Notification
2026
Mar 27
Capital/Financing Update
2026
Mar 2